CVE-2025-68571

WordPress SALESmanago plugin <= 3.9.0 - Broken Access Control vulnerability

5.3 Medium

Missing Authorization vulnerability in SALESmanago SALESmanago & Leadoo salesmanago allows Exploiting Incorrectly Configured Access Control Security Levels.This issue affects SALESmanago & Leadoo: from n/a through <= 3.9.0.

Attack profile

How easy it is to exploit

Attack vector: Network
Complexity: Low
Privileges needed: None
User interaction: None

What an attacker can affect

Confidentiality: None
Integrity: Low
Availability: None

Exploit likelihood

0.25%Up 0.2 points since Dec 25, 2025

What each source reports

CVE List Score used 5.3

WordPress SALESmanago plugin <= 3.9.0 - Broken Access Control vulnerability

Record: CVE-2025-68571
CVSS 3.1: 5.3 MediumCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N
Weakness: CWE-862
Updated: 2026-11-02

EUVDEUVD-2025-205264 5.3

Record: EUVD-2025-205264
CVSS 3.1: 5.3 MediumCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N
Updated: 2026-11-02

GitHub AdvisoriesGHSA-2wpw-x29g-2vrh 8.8

Missing Authorization vulnerability in SALESmanago SALESmanago salesmanago allows Exploiting...

Missing Authorization vulnerability in SALESmanago SALESmanago salesmanago allows Exploiting Incorrectly Configured Access Control Security Levels.This issue affects SALESmanago: from n/a through <= 3.9.0.

Record: GHSA-2wpw-x29g-2vrh
CVSS 3.1: 8.8 HighCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness: CWE-862
Updated: 2026-11-02

NVD 5.3

Record: CVE-2025-68571
CVSS 3.1: 5.3 MediumCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N
Weakness: CWE-862
Updated: 2026-11-02

Affected products

salesmanago & leadoo

History

History
Recorded	Changed	Sources
Nov 2, 2026	first indexed	CVE List, EUVD, GitHub Advisories, NVD

Dates are when Every CVE recorded each change. Upstream dates may differ.

In short

CVE-2025-68571 is a medium vulnerability (CVSS 5.3) in Salesmanago & Leadoo, published December 24, 2025. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.25%, the 17th percentile. No source names a fixed version.